Table 2.

Demographics of Study Population

COVID vs VRICOVID vs No InfectionVRI vs No Infection
CharacteristicsPatients With SARS-CoV-2, No. (%)Patients With VRI, No. (%)PPatients With SARS-CoV-2, No. (%)Patients With No Infection, No. (%)PPatients With VRI, No. (%)Patients With No Infection No. (%)P
Total17 487 (100.0)17 487 (100.0)-15 694 (100.0)15 694 (100.0)15 694 (100.0)15 694 (100.0)
Demographics
Age
 18–24 y1871 (10.7)1764 (10.1).06081436 (9.1)1609 (10.3).0011578 (10.1)1609 (10.3).5624
 25–34 y2534 (14.5)2572 (14.7).5652190 (14.0)2290 (14.6).10662288 (14.6)2290 (14.6).9745
 35–49 y3717 (21.3)3797 (21.7).29763394 (21.6)3346 (21.3).50943409 (21.7)3346 (21.3).3869
 50–64 y4525 (25.9)4655 (26.6).11414207 (26.8)4130 (26.3).32514192 (26.7)4130 (26.3).4279
 65–80 y3839 (22.0)3701 (21.2).07273540 (22.6)3342 (21.3).00693349 (21.3)3342 (21.3).9231
 >80 y1001 (5.7)998 (5.7).9449927 (5.9)977 (6.2).2371878 (5.6)977 (6.2).0178
Sex
 Sex: male5919 (33.8)5921 (33.9).9825362 (34.2)5108 (32.5).00245278 (33.6)5108 (32.5).0414
 Sex: female11 560 (66.1)11 561 (66.1).99110 324 (65.8)10 581 (67.4).002110 411 (66.3)10 581 (67.4).0415
Race/ethnicity
 Race: White12 816 (73.3)12 802 (73.2).865711 353 (72.3)11 578 (73.8).004211 533 (73.5)11 578 (73.8).5643
 Race: Black1794 (10.3)1723 (9.9).20681591 (10.1)1479 (9.4).03331520 (9.7)1479 (9.4).4311
 Race: Hispanic720 (4.1)737 (4.2).6491699 (4.5)504 (3.2)<.0001598 (3.8)504 (3.2).0039
 Race: Asian273 (1.6)254 (1.5).4043244 (1.6)239 (1.5).8187239 (1.5)239 (1.5)1
 Race: other1884 (10.8)1971 (11.3).13741807 (11.5)1894 (12.1).12781804 (11.5)1894 (12.1).1151
COVID vs VRICOVID vs No InfectionVRI vs No Infection
CharacteristicsPatients With SARS-CoV-2, No. (%)Patients With VRI, No. (%)PPatients With SARS-CoV-2, No. (%)Patients With No Infection, No. (%)PPatients With VRI, No. (%)Patients With No Infection No. (%)P
Total17 487 (100.0)17 487 (100.0)-15 694 (100.0)15 694 (100.0)15 694 (100.0)15 694 (100.0)
Demographics
Age
 18–24 y1871 (10.7)1764 (10.1).06081436 (9.1)1609 (10.3).0011578 (10.1)1609 (10.3).5624
 25–34 y2534 (14.5)2572 (14.7).5652190 (14.0)2290 (14.6).10662288 (14.6)2290 (14.6).9745
 35–49 y3717 (21.3)3797 (21.7).29763394 (21.6)3346 (21.3).50943409 (21.7)3346 (21.3).3869
 50–64 y4525 (25.9)4655 (26.6).11414207 (26.8)4130 (26.3).32514192 (26.7)4130 (26.3).4279
 65–80 y3839 (22.0)3701 (21.2).07273540 (22.6)3342 (21.3).00693349 (21.3)3342 (21.3).9231
 >80 y1001 (5.7)998 (5.7).9449927 (5.9)977 (6.2).2371878 (5.6)977 (6.2).0178
Sex
 Sex: male5919 (33.8)5921 (33.9).9825362 (34.2)5108 (32.5).00245278 (33.6)5108 (32.5).0414
 Sex: female11 560 (66.1)11 561 (66.1).99110 324 (65.8)10 581 (67.4).002110 411 (66.3)10 581 (67.4).0415
Race/ethnicity
 Race: White12 816 (73.3)12 802 (73.2).865711 353 (72.3)11 578 (73.8).004211 533 (73.5)11 578 (73.8).5643
 Race: Black1794 (10.3)1723 (9.9).20681591 (10.1)1479 (9.4).03331520 (9.7)1479 (9.4).4311
 Race: Hispanic720 (4.1)737 (4.2).6491699 (4.5)504 (3.2)<.0001598 (3.8)504 (3.2).0039
 Race: Asian273 (1.6)254 (1.5).4043244 (1.6)239 (1.5).8187239 (1.5)239 (1.5)1
 Race: other1884 (10.8)1971 (11.3).13741807 (11.5)1894 (12.1).12781804 (11.5)1894 (12.1).1151

P values were calculated using a 2-tailed chi-square test.

Abbreviations: SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; VRI, viral respiratory infection.

Table 2.

Demographics of Study Population

COVID vs VRICOVID vs No InfectionVRI vs No Infection
CharacteristicsPatients With SARS-CoV-2, No. (%)Patients With VRI, No. (%)PPatients With SARS-CoV-2, No. (%)Patients With No Infection, No. (%)PPatients With VRI, No. (%)Patients With No Infection No. (%)P
Total17 487 (100.0)17 487 (100.0)-15 694 (100.0)15 694 (100.0)15 694 (100.0)15 694 (100.0)
Demographics
Age
 18–24 y1871 (10.7)1764 (10.1).06081436 (9.1)1609 (10.3).0011578 (10.1)1609 (10.3).5624
 25–34 y2534 (14.5)2572 (14.7).5652190 (14.0)2290 (14.6).10662288 (14.6)2290 (14.6).9745
 35–49 y3717 (21.3)3797 (21.7).29763394 (21.6)3346 (21.3).50943409 (21.7)3346 (21.3).3869
 50–64 y4525 (25.9)4655 (26.6).11414207 (26.8)4130 (26.3).32514192 (26.7)4130 (26.3).4279
 65–80 y3839 (22.0)3701 (21.2).07273540 (22.6)3342 (21.3).00693349 (21.3)3342 (21.3).9231
 >80 y1001 (5.7)998 (5.7).9449927 (5.9)977 (6.2).2371878 (5.6)977 (6.2).0178
Sex
 Sex: male5919 (33.8)5921 (33.9).9825362 (34.2)5108 (32.5).00245278 (33.6)5108 (32.5).0414
 Sex: female11 560 (66.1)11 561 (66.1).99110 324 (65.8)10 581 (67.4).002110 411 (66.3)10 581 (67.4).0415
Race/ethnicity
 Race: White12 816 (73.3)12 802 (73.2).865711 353 (72.3)11 578 (73.8).004211 533 (73.5)11 578 (73.8).5643
 Race: Black1794 (10.3)1723 (9.9).20681591 (10.1)1479 (9.4).03331520 (9.7)1479 (9.4).4311
 Race: Hispanic720 (4.1)737 (4.2).6491699 (4.5)504 (3.2)<.0001598 (3.8)504 (3.2).0039
 Race: Asian273 (1.6)254 (1.5).4043244 (1.6)239 (1.5).8187239 (1.5)239 (1.5)1
 Race: other1884 (10.8)1971 (11.3).13741807 (11.5)1894 (12.1).12781804 (11.5)1894 (12.1).1151
COVID vs VRICOVID vs No InfectionVRI vs No Infection
CharacteristicsPatients With SARS-CoV-2, No. (%)Patients With VRI, No. (%)PPatients With SARS-CoV-2, No. (%)Patients With No Infection, No. (%)PPatients With VRI, No. (%)Patients With No Infection No. (%)P
Total17 487 (100.0)17 487 (100.0)-15 694 (100.0)15 694 (100.0)15 694 (100.0)15 694 (100.0)
Demographics
Age
 18–24 y1871 (10.7)1764 (10.1).06081436 (9.1)1609 (10.3).0011578 (10.1)1609 (10.3).5624
 25–34 y2534 (14.5)2572 (14.7).5652190 (14.0)2290 (14.6).10662288 (14.6)2290 (14.6).9745
 35–49 y3717 (21.3)3797 (21.7).29763394 (21.6)3346 (21.3).50943409 (21.7)3346 (21.3).3869
 50–64 y4525 (25.9)4655 (26.6).11414207 (26.8)4130 (26.3).32514192 (26.7)4130 (26.3).4279
 65–80 y3839 (22.0)3701 (21.2).07273540 (22.6)3342 (21.3).00693349 (21.3)3342 (21.3).9231
 >80 y1001 (5.7)998 (5.7).9449927 (5.9)977 (6.2).2371878 (5.6)977 (6.2).0178
Sex
 Sex: male5919 (33.8)5921 (33.9).9825362 (34.2)5108 (32.5).00245278 (33.6)5108 (32.5).0414
 Sex: female11 560 (66.1)11 561 (66.1).99110 324 (65.8)10 581 (67.4).002110 411 (66.3)10 581 (67.4).0415
Race/ethnicity
 Race: White12 816 (73.3)12 802 (73.2).865711 353 (72.3)11 578 (73.8).004211 533 (73.5)11 578 (73.8).5643
 Race: Black1794 (10.3)1723 (9.9).20681591 (10.1)1479 (9.4).03331520 (9.7)1479 (9.4).4311
 Race: Hispanic720 (4.1)737 (4.2).6491699 (4.5)504 (3.2)<.0001598 (3.8)504 (3.2).0039
 Race: Asian273 (1.6)254 (1.5).4043244 (1.6)239 (1.5).8187239 (1.5)239 (1.5)1
 Race: other1884 (10.8)1971 (11.3).13741807 (11.5)1894 (12.1).12781804 (11.5)1894 (12.1).1151

P values were calculated using a 2-tailed chi-square test.

Abbreviations: SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; VRI, viral respiratory infection.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close